ArriVent BioPharma, Inc. (NASDAQ:AVBP) currently has 117 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| INFINITUM ASSET MANAGEMENT, LLC | 31 Dec, 2025 | 4,123,923 | 255,000 | 6.59% | $82,973,331.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 4,106,035 | 402,583 | 10.87% | $82,613,424.00 |
| HHLR ADVISORS, LTD. | 31 Dec, 2025 | 3,929,117 | -555,555 | -12.39% | $79,053,834.00 |
| FMR LLC | 31 Dec, 2025 | 3,703,572 | 296,023 | 8.69% | $74,515,872.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 3,027,328 | 0 | 0.00% | $60,909,839.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 2,372,838 | 326,700 | 15.97% | $47,741,500.00 |
| Octagon Capital Advisors LP | 31 Dec, 2025 | 1,971,054 | 0 | 0.00% | $39,657,606.00 |
| Novo Holdings A/S | 31 Dec, 2025 | 1,942,142 | 0 | 0.00% | $39,075,897.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,869,266 | -160,265 | -7.90% | $37,609,632.00 |
| Sofinnova Investments, Inc. | 31 Dec, 2025 | 1,696,752 | 0 | 0.00% | $34,138,650.00 |
| General Catalyst Group Management, LLC | 31 Dec, 2025 | 1,494,786 | 0 | 0.00% | $30,075,094.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,091,980 | 64,352 | 6.26% | $21,970,638.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 753,519 | 37,231 | 5.20% | $15,164,192.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 742,526 | 310,587 | 71.91% | $14,939,623.00 |
| HSG Holding Ltd | 31 Dec, 2025 | 663,308 | 0 | 0.00% | $16,715,362.00 |
| AIHC Capital Management Ltd | 31 Dec, 2025 | 644,788 | 644,788 | 0.00% | $12,973,135.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 458,502 | 458,502 | 0.00% | $9,225,060.00 |
| UBS Group AG | 31 Dec, 2025 | 450,920 | -46,681 | -9.38% | $9,072,510.00 |
| Squadron Capital Management LLC | 31 Dec, 2025 | 338,000 | 338,000 | 0.00% | $6,800,560.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 281,952 | -4,152 | -1.45% | $5,672,874.00 |